PAK4 and breast carcinoma: PKD3 was constitutively active in MDA-MB-468 breast cancer cells under normal growth conditions, and this basal activity was sufficient to stimulate PAK4/LIMK signaling without affecting SSH1L activity, which contributed to a functional cofilin activity cycle and directed cell migration by activating PAK4 [88].